Hesperidin prevents hyperglycemia in diabetic rats by activating the insulin receptor pathway
Authors:
- 19 November 2020
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 21 (1) , 1
Abstract
Diabetes, a disease with high prevalence in China, is a major risk factor of cardiovascular disease. Hesperidin is a flavanone glycoside with anti‑hyperglycemic and anti‑hyperlipidemic activities. Therefore, the present study aimed to investigate the potential preventive effect of hesperidin against type 2 diabetes mellitus (T2DM) using a rat model of alloxan and high fat diet (HFD)‑induced insulin resistance. Male Sprague Dawley rats were orally administered with 100 mg/kg hesperidin or vehicle (sodium carboxy methyl cellulose) for 35 days. Insulin resistance was induced by feeding animals a HFD for 3 weeks (from day 7) and then with an alloxan injection on day 28. Results from the in vivo study demonstrated that hesperidin improved fasting serum glucose (from 19.8 to 10.6 mmol/l) without changing the fasting insulin level, suggesting that hesperidin prevented the development of insulin resistance and diabetes by improving insulin sensitivity. In the oral glucose tolerance test, the development of impaired glucose tolerance was also prevented by hesperidin treatment. Hesperidin was found to regulate glycolysis and gluconeogenesis by enhancing the activity of glucokinase, inducing the phosphorylation of insulin receptor (IR) and phosphoinositide‑dependent kinase 1 (PDK1), while decreasing the activity of glucose‑6‑phosphatase and phosphoenolpyruvate carboxykinase in the liver. In a cell‑based assay, hesperidin increased glucose uptake in primary rat adipocytes. Collectively, the present study identified the potent preventive effect of hesperidin against HFD‑induced insulin resistance by activating the IR/PDK1 pathway. The current results may provide a potential strategy lacking sides effects to improve metabolic health and reduce risks.Keywords
This publication has 42 references indexed in Scilit:
- Hesperidin Prevents Retinal and Plasma Abnormalities in Streptozotocin-Induced Diabetic RatsMolecules, 2012
- Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cellsCell Biochemistry and Function, 2012
- Molecular docking studies of banana flower flavonoids as insulin receptor tyrosine kinase activators as a cure for diabetes mellitusBioinformation, 2012
- The insulin and insulin-like growth factor receptor family in neoplasia: an updateNature Reviews Cancer, 2012
- A retrospective review of the roles of multifunctional glucose-6-phosphatase in blood glucose homeostasis: Genesis of the tuning/retuning hypothesisLife Sciences, 2010
- Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPKBiochemical and Biophysical Research Communications, 2010
- Hypoglycemic and Hypolipidemic Effects of Hesperidin and Cyclodextrin-Clathrated Hesperetin in Goto-Kakizaki Rats with Type 2 DiabetesBioscience, Biotechnology, and Biochemistry, 2009
- HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS)Archives of Endocrinology and Metabolism, 2009
- Quercetin selectively inhibits insulin receptor function in vitro and the bioresponses of insulin and insulinomimetic agents in rat adipocytesBiochemistry, 1992
- Improvement of Hyperglycemia and Hyperlipemia in Streptozotocin-Diabetic Rats by a Methanolic Extract ofPrunus davidianaStems and Its Main Component, PruninPlanta Medica, 1991